Healthcare & Life Sciences
Ecrins Therapeutics
Ecrins Therapeutics is a Healthcare & Life Sciences startup based in France, most recent round Series C+, 2 tracked investors.
Defunctseries-c-plus
series-c-plus
Stage
2
Investors
About Ecrins Therapeutics
Ecrins Therapeutics is a company headquartered in France. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Ecrins Therapeutics is a French biotechnology company developing innovative anti-cancer drugs. Their approach targets tumor metabolism with a new mechanism of action.
Explore Ecrins Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.